Tricyclic compound as CRTH2 inhibitor

US11524958B2 · kind B2 · utility

Assignee

• Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · CN

Inventors

• Bin Chen · Shanghai, CN
• Yuanshan Yao · Shanghai, CN
• Yuan Chen · Shanghai, CN
• Ao Li · Nanjing, CN
• Ran Xu · Houston, US
• Zhensheng Huang · Shanghai, CN
• Dongdong Tian · Tangxia, CN
• Hongwei Li · Burnaby, CA
• Chengshuai Yang · Shanghai, CN
• Jian Li · Shanghai, CN
• Shuhui CHEN · Shanghai, CN

Key dates

• Filing date: Jul 21, 2017
• Grant date: Dec 13, 2022
• Expiry date: Feb 12, 2040

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D487/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Provided are a tricyclic compound as shown in formula (I) as a CRTH2 inhibitor, or a pharmaceutically acceptable salt, a tautomer, a stereoisomer or a solvate thereof, and the use thereof in treating diseases related to CRTH2 receptors.